Investors eye U.S. GDP data
The Stoxx 600 reached a new intra-day high, with investors focusing on upcoming U.S. GDP data. Novo Nordisk shares rose significantly on the potential U.S. approval of a pill form of its weight-loss drug.
The Stoxx 600 reached a new intra-day high, with investors focusing on upcoming U.S. GDP data. Novo Nordisk shares rose significantly on the potential U.S. approval of a pill form of its weight-loss drug.